key: cord-0984414-j8yrxwe5
authors: Francis, Rodric V; Billam, Harriet; Clarke, Mitch; Yates, Carl; Tsoleridis, Theocharis; Berry, Louise; Mahida, Nikunj; Irving, William L; Moore, Christopher; Holmes, Nadine; Ball, Jonathan; Loose, Matthew; McClure, C Patrick
title: The impact of real-time whole genome sequencing in controlling healthcare-associated SARS-CoV-2 outbreaks
date: 2021-09-23
journal: J Infect Dis
DOI: 10.1093/infdis/jiab483
sha: a70927049f6e31d4fe76b2c8ebb15955dd007371
doc_id: 984414
cord_uid: j8yrxwe5

Nosocomial SARS-CoV-2 infections have severely affected bed capacity and patient flow. We utilised whole genome sequencing (WGS) to identify outbreaks and focus infection control resources and intervention during the UK’s second pandemic wave in late 2020. Phylogenetic analysis of WGS and epidemiological data pinpointed an initial transmission event to an admission ward, with immediate prior community infection linkage documented. High incidence of asymptomatic staff infection with genetically identical viral sequences was also observed, which may have contributed to the propagation of the outbreak. WGS allowed timely nosocomial transmission intervention measures, including admissions ward point of care testing and introduction of portable HEPA14 filters. Conversely WGS excluded nosocomial transmission in two instances with temporospatial linkage, conserving time and resources. In summary, WGS significantly enhanced understanding of SARS-CoV-2 clusters in a hospital setting, both identifying high risk areas and conversely validating existing control measures in other units, maintaining clinical service overall.

A c c e p t e d M a n u s c r i p t 5

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has become a global concern since being first reported in Wuhan, China in December 2019 [1] . As of 10 th May 2021, the UK has reported 4,437,217 cases with 127,609 deaths [2] and 463,820 hospital admissions. The clinical spectrum of COVID-19 infection is wide, ranging from asymptomatic infection to severe viral pneumonia leading to death [3, 4] . SARS-CoV-2 is highly transmissible by droplet and indirect contact [5] . Viral load in asymptomatic patients may be similar to those who are symptomatic [6] . The sensitivity of COVID-19 testing ranges from 71-98% [7] . This combination of factors poses a significant challenge in infection control.

Nosocomial transmission has been widely reported [8] [9] [10] [11] [12] [13] [14] . An early report from Wuhan showed that of 138 hospitalised COVID-19 cases, 12% were identified as being admitted for other reasons and presumed to have acquired the infection in hospital [14] . Transmission between hospital staff has also been demonstrated [13] . Retrospective analysis in a London teaching hospital showed nosocomial COVID-19 had a case fatality rate of 36% [11] .

At Nottingham University Hospitals (NUH) Trust, United Kingdom, the Infection Prevention and Control team (IPCT) along with Clinical Microbiology colleagues have hitherto solely relied on epidemiological data to track outbreaks of viral pathogens [15] . Previously whole genome sequencing (WGS) has been used retrospectively to prove/disprove results of outbreak investigations [16] . Coronavirus Disease 2019 (COVID-19) Genomics UK Consortium (COG-UK) was set up in March 2020 to drive WGS nationally [17] , and over 450,000 viral genomes have been sequenced (as of 10 th May 2021). This is the first pandemic where WGS technology has been widely accessible in a clinically relevant timeframe, allowing exploration of its utility in a range of clinical scenarios [18] [19] [20] [21] .

A c c e p t e d M a n u s c r i p t 6 We present a series of epidemiologically linked hospital clusters where WGS of SARS-CoV-2 isolates has directly affected real time outbreak management.

All patients were tested for SARS-CoV-2 infection on admission to NUH Trust, irrespective of symptomatology. All samples underwent RT-PCR through one of four different molecular platforms (Supplementary information). Use of surplus nucleic acid derived from routine diagnostics and associated patient data was approved through the COG-UK consortium by the PHE Research Ethics and Governance Group (R&D NR0195).

At the time of analysis, all inpatients with negative admission tests were re-tested every 7 days.

Patients who tested negative on admission but fulfilled clinical criteria for COVID-19 infection were managed similarly to positive patients.

Positive patients were moved to a COVID-19 ward where they were isolated in a side room or cohorted with other positive patients in a bay. Patients negative for COVID-19 were moved to a non-COVID-19 ward. If a bed was not available immediately, patients were isolated or cohorted appropriately on the admissions ward until a bed became available. Type IIR surgical mask, plastic apron and gloves were used as standard personal protective equipment (PPE) on all wards when caring for patients, with enhanced PPE when aerosol generating procedures were carried out. Staff were advised to always wear Type IIR surgical masks when inside the hospital which should only have been removed when consuming food or drink.

Symptomatic staff testing was also undertaken. During outbreaks, asymptomatic screening of all healthcare workers who worked in the particular area of concern was also undertaken. Until November 2020, there was no routine asymptomatic healthcare worker testing. The average turnaround time to SARS-CoV-2 results was 11.5 hours from when the swab was received in the laboratory. Results were alerted to the clinical team electronically as soon they were available.

A c c e p t e d M a n u s c r i p t 7 Samples with a positive RT-PCR result (with cycle threshold of <35) and suggestive epidemiological linkage underwent WGS. For routine surveillance of viral sequences not flagged by epidemiological linkage, samples testing positive on the Altona platform with a cycle threshold value of <30 were selected for sequencing. WGS was performed using the ARTIC amplicon sequencing protocol on Oxford Nanopore GridION sequencers to enable rapid turnaround [22] (Supplementary information). V3 primers (as described at https://github.com/artic-network/primer-schemes/tree/master/nCoV-2019/V3) were used for all samples. Samples were typically sequenced and analysed within 72 hours of collection, with analysis using the artic pipeline as described in [22] . Daily communication between the IPC team and sequencing laboratory identified all new positives within the last 24 hours and enabled randomised sample selection as well as targeted sample collection for further investigation. All samples in this study are available through GISAID (if coverage >90%), from COG-UK (https://www.cogconsortium.uk/tools-analysis/public-data-analysis-2/) or via ENA. A table of COG-UK IDs used in this study is provided (see Supplementary Table 1 ). Samples were analysed using the CIVET tool (version 2 -https://github.com/artic-network/civet ) in real time. Further analysis is as described in the supplementary text.

Patients with a diagnosis of a respiratory condition were admitted from both the Emergency Department (ED), as well as directly from the community to a triage respiratory admissions ward, Ward X. A diagnosis of COVID-19 infection was based on a laboratory result, or more rarely on clinical criteria despite negative laboratory testing. Based on this, patients were transferred to a COVID-19 or a non-COVID-19 ward as appropriate.

Cluster 1 took place on Ward Y; an adult single sex non-COVID-19 respiratory ward, consisting of five bays with six beds in each and four side rooms. A timeline for this outbreak is shown in Figure 1 . previous studies of hospital acquired SARS-CoV-2 infection (data not shown, [11, 24, 25] Figure 3b ). Although impossible to prove, it is likely that some of these cases are from health care workers from these wards who were tested for COVID-19 in the community. Thus the most parsimonious explanation is that this outbreak originated with Patient C.

A c c e p t e d M a n u s c r i p t The only identified connection between them was that both patients travelled together regularly sharing the same ambulance transport to the dialysis unit. A third patient who was also in the ambulance car was negative on both initial screening and on re-testing 7 days later. The driver of the ambulance car was not tested and remained asymptomatic.

A review of the processes around transporting patients to the dialysis unit was undertaken. There was additional focus on appropriate mask usage in the car (type IIR surgical face mask). All patients when interviewed stated that the appropriate mask had been worn at all times in the car. Additional patient education of all patients travelling to the dialysis unit was undertaken in response to this event.

A c c e p t e d M a n u s c r i p t

Cluster 3 took place on a paediatric general surgical ward, Ward D, which has 11 beds and 4 side rooms. Patients arrive here from a paediatric admissions ward following initial review.

The first case identified (Patient A3) was an infant who had a 58 day inpatient stay following surgical intervention for a prolapsed stoma. During this admission the patient had a negative swab result, and was discharged 8 days later. Nine days following discharge they were readmitted with a positive (Figures 3a and 4) . Hence an outbreak was excluded and the ward returned to its normal processes.

The ability to use WGS data at scale to inform hospital outbreaks in close to real time has only been possible in the last decade [8, [28] [29] [30] . Most recently, it has become possible to routinely sequence samples within a 48-hour turnaround and feedback to clinical teams whilst an outbreak may be in progress. This has been facilitated by the co-ordinated work of the COG-UK consortium enabling distributed sequencing throughout the UK [17] . Here we present 3 clusters of SARS-CoV-2 infections which used this rapid feedback to directly inform active outbreak investigations, allowing the IPCT to A c c e p t e d M a n u s c r i p t 13 focus resources on genetically linked outbreaks, which was of particular value during periods of high SARS-CoV-2 positivity.

We have been able to identify transmission events occurring in our admission areas using genomics to support the likely routes of transmission. In the case of Cluster 1, the uniquely occurring SNP in the context of the specific lineage under observation suggests an outbreak initiating within the hospital and potentially spreading into the community. Mortality within this cluster was as would be expected at this period of the outbreak on these type of wards [11, 24, 25] .

From the examples presented, the severe impact of a hospital outbreak is evident. Cluster 1 resulted in numerous infections affecting multiple wards. The ongoing data stream provided by rapid WGS supplemented the IPCT epidemiological investigation and allowed identification of additional patients involved in the outbreak. As evidenced by the SNP profiles and phylogeny, patients in Cluster 1 with no direct contact still shared the same lineage. Given that many of the staff who tested positive were asymptomatic, they would have continued working until screening was performed as part of the outbreak management process.

Although the strain B.1.177 was abundant in the UK during the study period, accounting for nearly 75% of all cases in the region [27] , this cluster shared a unique SNP specific to this outbreak. In the course of our investigations, we also identified five samples linked to the index patient that had been diagnosed in the community. These individuals provide the community context by which this lineage entered the hospital but do not contain the SNP unique to the outbreak. There is no evidence at this time that this unique SNP confers any specific phenotype on the lineage. Coupled with the extensive epidemiological data supporting links between these patients and staff, Cluster 1 is a significant hospital outbreak. The application of WGS at the onset of this outbreak enabled the rapid identification of nosocomial transmission and linkage to other wards.

A c c e p t e d M a n u s c r i p t 14 Use of WGS allowed us to identify that transmission of SARS-CoV-2 was occurring in our respiratory admissions area, Ward X. Recognising this allowed us to alter practice quickly, introducing additional control measures. Following this outbreak, a Cepheid GeneXpert ® Xpress has been placed on Ward X as well as in the Emergency Department with support of the Point of Care Testing team to further reduce delays caused by transportation of samples [31] . This helps prompt isolation or cohorting of COVID-19 patients, reducing the risk of nosocomial spread to patients who are admitted due to another illness [32] . Air Sentry® HEPA14 air filters have also been deployed onto the admission wards as well as base wards where there has been increased nosocomial transmission [33] . Cluster 1 also highlighted that patients moving between wards can perpetuate ongoing transmission as occurred with Patient K (Supplementary Figure 1) . This cluster also emphasises the importance of future design planning of admission areas to ensure adequate isolation and effective ventilation is available [34] .

In Cluster 2, the WGS results and epidemiological link between the first two cases, strongly suggested that there had been one transmission event likely to have occurred whilst the patients shared transport as no other cases sharing the same WGS were identified in the dialysis unit. This helped close an outbreak investigation quickly, providing assurance that the infection prevention and processes applied within the unit were working well. To date there have been no other transmissions linked to patient transport following additional patient education and emphasis on mask wearing and hand hygiene during patient ambulance transport. This occurrence is similar to that seen in other health care contexts earlier in the pandemic [8] . Table 1 ). The colour scheme key denotes ward location and RT-PCR test results, with broken timelines indicating discharge and subsequent readmission of the patient. 

A new coronavirus associated with human respiratory disease in China

Severe Covid-19

Mild or Moderate Covid-19

Transmission of SARS-CoV-2 and Mitigating Measures -update

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

False-negative results of initial RT-PCR assays for COVID-19: A systematic review

Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study

Prevention of nosocomial COVID-19: Another challenge of the pandemic

Nosocomial outbreak of COVID-19 pneumonia in Wuhan, China

Nosocomial Transmission of Coronavirus Disease 2019: A Retrospective Study of 66 Hospital-acquired Cases in a London Teaching Hospital

Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong

Containment of a traceable COVID-19 outbreak among healthcare workers at a hematopoietic stem cell transplantation unit

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Management of an influenza A outbreak on an acute internal medicine ward

Use of Whole-Genome Sequencing of Adenovirus in

Immunocompromised Pediatric Patients to Identify Nosocomial Transmission and Mixed-Genotype Infection

An integrated national scale SARS-CoV-2 genomic surveillance network

Nosocomial Outbreak of SARS-CoV-2 in a "Non-COVID-19" Hospital Ward: Virus Genome Sequencing as a Key Tool to Understand Cryptic Transmission

Whole-genome Sequencing to Track Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in Nosocomial Outbreaks

Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data

Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting

Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United Kingdom

Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2

When Hospitals Harm: Multimodal Entry of SARS-CoV-2 into Inpatient Healthcare

Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial Study (COVID in Older PEople)

Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020

Estimated transmissibility and impact of SARS-CoV-2

Selected insights from application of whole-genome sequencing for outbreak investigations

Whole-genome Sequencing Provides Data for Stratifying Infection Prevention and Control Management of Nosocomial Influenza A

Use of Whole-Genome Sequencing in the Investigation of a Nosocomial Influenza Virus Outbreak

Impact of different SARS-CoV-2 assays on laboratory turnaround time

Point of Care Nucleic Acid Testing for SARS-CoV-2 in Hospitalized Patients: A Clinical Validation Trial and Implementation Study

Nosocomial outbreak of COVID-19 by possible airborne transmission leading to a superspreading event

How can airborne transmission of COVID-19 indoors be minimised?

A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t